Assembly Biosciences (ASMB) Net Cash Flow (QoQ) (2010 - 2026)
Assembly Biosciences (ASMB) Net Cash Flow (QoQ) (2010 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Assembly Biosciences |
418.96 Mn |
192.36 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-176.09% |
| Dec 31, 2025 |
2,539.95% |
| Sep 30, 2025 |
-348.23% |
| Jun 30, 2025 |
103.97% |
| Mar 31, 2025 |
-250.94% |
| Dec 31, 2024 |
7.01% |
| Sep 30, 2024 |
1,913.94% |
| Jun 30, 2024 |
142.03% |
| Mar 31, 2024 |
83.98% |
| Dec 31, 2023 |
-235.41% |
| Sep 30, 2023 |
123.02% |
| Jun 30, 2023 |
-144.62% |
| Mar 31, 2023 |
-296.27% |
| Dec 31, 2022 |
-119.42% |
| Sep 30, 2022 |
243.14% |
| Jun 30, 2022 |
-246.22% |
| Mar 31, 2022 |
122.07% |
| Dec 31, 2021 |
-323.54% |
| Sep 30, 2021 |
160.01% |
| Jun 30, 2021 |
-199.61% |
